Publications

Ventas acquires life science portfolio from Bain and Phase 3 for $1b
Transactions - OCTOBER 16, 2020

To read this full article you need to be subscribed to Newsline.

Sign in Sign up for a FREE subscription

Ventas acquires life science portfolio from Bain and Phase 3 for $1b

by Andrea Zander

Bain Capital Real Estate, the real estate investing business of Bain Capital, and Phase 3 Real Estate Partners have sold Genesis South San Francisco, a class A life sciences portfolio located at the entrance to the South San Francisco life science cluster, one of the largest life science clusters in the world.

The premier, three-building portfolio has been sold Ventas in a transaction valued at approximately $1.02 billion. The trophy life science portfolio was acquired by the Ventas Life Science and Healthcare Real Estate Fund.

“Strong and growing capital flows into the life science sector are accelerating innovation and discovery,” said Debra Cafaro, chairman and CEO of Ventas. “These flows support the demand for first-class lab space in dynamic markets like South San Francisco. Ventas now owns or has an investment in over 7 million square feet of research and innovation properties located in the life science clusters of Cambridge, South San Francisco, and on th

Forgot your username or password?